| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Sprouts Farmers Markets (SFM) | Goldman, Sachs/ Credit Suisse/ BofA Merrill Lynch | $300.00 | n.a. | |||
| QEP Midstream Partners, LP (QEPM) | Wells Fargo Securities | $400.00 | n.a. | |||
| Heat Biologics (HEAX) | Aegis Capital Corp. | $18.90 | n.a. | |||
| Franks International N.V. (FI) | Barclays/ Credit Suisse/ Simmons & Company | $500.00 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| Quicksilver Production Partners LP (QPP) | J.P. Morgan/ Credit Suisse | $250.00 | 1-Star | |||
| New Terms | ||||||
| BioAmber (BIOA) | Credit Suisse | 8.00 | $10.00 | $12.00 | $88.00 | 1-Star |
| ChannelAdvisor (ECOM) | Goldman, Sachs/ Stifel | 5.75 | $12.00 | $14.00 | $74.75 | 2-Stars |
| Marketo (MKTO) | Goldman, Sachs/ Credit Suisse | 6.06 | $11.00 | $13.00 | $72.71 | 2-Stars |
| Ply Gen Holdings (PGEM) | J.P. Morgan/ Credit Suisse/ Goldman, Sachs/ UBS Investment Bank/ Deutsche Bank Securities | $345.00 | 1-Star | |||
| Portola Pharmaceuticals (PTLA) | Morgan Stanley/ Credit Suisse | 6.90 | $13.00 | $16.00 | $100.05 | 1-Star |
| RCS Capital (RCAP) | JMP Securities/ Ladenburg Thalmann | 2.75 | $19.00 | $21.00 | $55.00 | |
| Tableau Software ( DATA) | Goldman, Sachs/ Morgan Stanley | 7.20 | $23.00 | $26.00 | $176.40 | 2-Stars |
| Tallgrass Energy Partners, LP (TEP) | Barclays/ Citigroup | 13.05 | $21.00 | $23.00 | $287.10 | 1-Star |
| William Lyon Homes (WLH) | Credit Suisse/ Citigroup/ J.P. Morgan | 8.70 | $22.00 | $24.00 | $200.10 | 2-Stars |
| u (unit offering) | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of May 6, 2013 | Manager(s) | Offered | Raised | Price | 5/19/13 | Change |
| TriState Capital Holdings (TSC) | Stephens/ Keefe, Bruyette & Woods (A Stifel Company)/ Baird | 5.70 | $65.55 | $11.50 | $12.65 | 10.00% |
| PennyMac Financial Services (PFSI) | Citigroup/ BofA Merrill Lynch/ Credit Suisse/ Goldman, Sachs | 11.11 | $200.00 | $18.00 | $19.60 | 8.89% |
| Quintiles Transnational Holdings (Q) | Morgan Stanley/ Barclays/ J.P. Morgan | 23.68 | $947.37 | $40.00 | $42.39 | 5.98% |
| First NBC Bank Holding (NBCB) | SANDLER O’NEILL + PARTNERS/ Keefe, Bruyette & Woods (A Stifel Company ) | 4.17 | $100.00 | $24.00 | $24.50 | 2.08% |
| Receptos (RCPT) | Credit Suisse/ Leerink Swann/ BMO Capital Markets | 5.20 | $72.80 | $14.00 | $14.20 | 1.43% |
| CYAN (CYNI) | Goldman, Sachs/ J.P. Morgan | 8.00 | $88.00 | $11.00 | $11.11 | 1.00% |
| Armada Hoffler Properties (AHH) | Baird/ Raymond James/ Stifel | 16.50 | $189.75 | $11.50 | $11.60 | 0.87% |
| Capitol Acquisition (CLAQU) | Citigroup/ Deutsche Bank Securities | 18.00 | $180.00 | $10.00 | $10.01 | 0.10% |
| American Residential Properties (ARPI) | Morgan Stanley/ BofA Merrill Lynch/ FBR/ Jefferies | 13.70 | $287.71 | $21.00 | $21.00 | 0.00% |
| Emerge Energy Services LP (EMES) | Citigroup/ Wells Fargo Securities/ J.P. Morgan | 7.50 | $127.50 | $17.00 | $16.70 | -1.76% |
| BioAmber (BIOA)(u) | Credit Suisse | 8.00 | $80.00 | $10.00 | $8.60 | -14.00% |
